United States

Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

24 Apr 2017
Change (% chg)

$0.37 (+1.19%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Tue, Feb 14 2017

BRIEF-Genomic Health Q4 EPS $0.04

* Genomic health announces 2016 fourth quarter and year-end financial results, provides 2017 financial outlook

BRIEF-Genomic Health Q3 loss per share $0.08

* Genomic Health reports third consecutive quarter of double-digit revenue growth in announcement of third quarter 2016 financial results

BRIEF-Genomic Health reports positive topline clinical validation study results

* Genomic Health announces positive topline clinical validation study results demonstrating Oncotype DX prostate cancer test predicts risk of metastasis and mortality Source text for Eikon: Further company coverage:

Select another date:

More From Around the Web